✦ LIBER ✦

A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome

✍ Scribed by Erkan, Doruk; Vega, JoAnn; Ramón, Glendalee; Kozora, Elizabeth; Lockshin, Michael D.

Book ID: 118752760
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 84 KB
Volume: 65
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.37759

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II, open-label, non-comparative

A phase II, open-label, non-comparative study of Botulinum toxin in Restless Legs Syndrome

✍ Ghorayeb, Imad; Bénard, Antoine; Vivot, Alexandre; Tison, François; Burbaud, Pie 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 148 KB

269: A Phase II Open Label Pilot Trial o

269: A Phase II Open Label Pilot Trial of Empiric Daptomycin Treatment for Hematology-Oncology Patients with Febrile Neutropenia (FN)

✍ J.S. Bubalo; A.O. Ciszewski; T.J. Kovascovics; G. Meyers; M. Mauro; E. Epner; N. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Results of a phase II open-label, non-ra

Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients withBRCA1-positive metastatic breast cancer

✍ Tomasz Byrski, Rebecca Dent, Pawel Blecharz, Malgorzata Foszczynska-Kloda, Jacek 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 269 KB

Rituximab Plus Chlorambucil As First-Lin

Rituximab Plus Chlorambucil As First-Line Treatment for Chronic Lymphocytic Leukemia: Final Analysis of an Open-Label Phase II Study

✍ Hillmen, P.; Gribben, J. G.; Follows, G. A.; Milligan, D.; Sayala, H. A.; Moreto 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 141 KB

Quetiapine as an adjunctive pharmacother

Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: A flexible-dose, open-label pilot trial

✍ M.A. Katzman; M. Vermani; L. Jacobs; M. Marcus; B. Kong; S. Lessard; W. Galarrag 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Phase II trial of the combination of den

Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma

✍ Nam H. Dang; Luis Fayad; Peter McLaughlin; Jorge E. Romaguara; Fredrick Hagemeis 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 447 KB